Free shipping on all orders over $ 500

PF-3644022 

Cat. No. M28107

All AbMole products are for research use only, cannot be used for human consumption.

PF-3644022  Structure

Price and Availability

For this product's availability, delivery time and price, please email inquiry@abmole.com directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

PF-3644022 is a potent, selective, orally active and ATP-competitive MAPKAPK2 (MK2) inhibitor with an IC50 of 5.2 nM and a Ki of 3 nM. PF-3644022 also inhibits MK3 and p38 regulated/activated kinase (PRAK) with IC50s of 53 nM and 5.0 nM, respectively. PF-3644022 potently inhibits TNFα production and has anti-inflammatory effect.

Chemical Information
Molecular Weight 374.46
Formula C21H18N4OS
CAS Number 1276121-88-0
Form Solid
Solubility (25°C) DMSO 41.67 mg/mL (ultrasonic and warming and heat to 60°C)
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Lei Yu, et al. Ann Palliat Med. Role of MK2 signaling pathway mediating microglia/macrophages polarization in chronic compression injury of cervical spinal cord

[2] Kiersten L Berggren, et al. Oncogene. MAPKAPK2 (MK2) inhibition mediates radiation-induced inflammatory cytokine production and tumor growth in head and neck squamous cell carcinoma

[3] Yizhu Li, et al. Cancer Lett. Inhibition of MAPKAPK2/MK2 facilitates DNA replication upon cancer cell treatment with gemcitabine but not cisplatin

[4] Hongxing Song, et al. Am J Transl Res. Role of MK2 signaling pathway in the chronic compression of cervical spinal cord

[5] Robert J Mourey, et al. J Pharmacol Exp Ther. A benzothiophene inhibitor of mitogen-activated protein kinase-activated protein kinase 2 inhibits tumor necrosis factor alpha production and has oral anti-inflammatory efficacy in acute and chronic models of inflammation

Related MAPKAPK2/MAP3K/MAP4K Products
Takinib

Takinib is a potent and selective TAK1 inhibitor with an IC50 of 9.5 nM, more than 1.5 log more potent than the second and third ranked targets, IRAK4 (120 nM) and IRAK1 (390 nM), respectively.

GNE-495

GNE-495 is a potent and selective MAP4K4 inhibitor with an IC50 of 3.7 nM.

NG25

NG25 is a potent dual TAK1 and MAP4K2 inhibitor with IC50s of 149 nM and 21.7 nM, respectively.

PF-06260933

PF-06260933 is a potent inhibitor of MAP4K4 with an IC50 of 3.7 nM, possessing excellent kinome selectivity.

MAP4K4-IN-3

MAP4K4-IN-3 is a potent and selective MAP4K4 inhibitor with an IC50 of 14.9 nM in kinase assay, and an IC50 of 470 nM in cell assay.

  Catalog
Abmole Inhibitor Catalog




Keywords: PF-3644022  supplier, MAPKAPK2/MAP3K/MAP4K, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.